Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | |||||||
| Earning before tax | ---- | 134.86%2.35B | ---- | 22.70%-6.74B | ---1.89B | -317.41%-8.72B | ---2.09B |
| Profit adjustment | |||||||
| Investment loss (gain) | ---- | 397.25%557.29M | ---- | 226.77%112.07M | --16.8M | 1,255.65%34.3M | --2.53M |
| Impairment and provisions: | ---- | 146.25%69.21M | ---- | 111.22%28.11M | --7.17M | 49.42%13.31M | --8.91M |
| -Impairmen of inventory (reversal) | ---- | 145.62%17.97M | ---- | 2,629.10%7.31M | --4K | -92.96%268K | --3.81M |
| -Other impairments and provisions | ---- | 146.47%51.25M | ---- | 59.47%20.79M | --7.16M | 155.77%13.04M | --5.1M |
| Revaluation surplus: | ---- | -199.83%-4.74B | ---- | -28.29%4.75B | --713.45M | 761.29%6.63B | --769.27M |
| -Other fair value changes | ---- | -199.83%-4.74B | ---- | -28.29%4.75B | --713.45M | 761.29%6.63B | --769.27M |
| Asset sale loss (gain): | ---- | -24.52%973K | ---- | 441.60%1.29M | --62K | -93.17%238K | --3.49M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---623K | ---- | ---- | --3.14M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -49.11%973K | ---- | 703.36%1.91M | --62K | -30.81%238K | --344K |
| Depreciation and amortization: | ---- | 22.91%438.47M | ---- | 21.77%356.73M | --170.72M | 90.61%292.97M | --153.7M |
| -Amortization of intangible assets | ---- | 16.28%265.48M | ---- | 22.67%228.32M | --108.64M | 142.82%186.12M | --76.65M |
| Financial expense | ---- | -14.31%7.41M | ---- | 14.61%8.65M | --4.59M | -54.51%7.55M | --16.59M |
| Exchange Loss (gain) | ---- | -119.21%-7.75M | ---- | -84.76%40.33M | --63.16M | 2,488.63%264.66M | ---11.08M |
| Special items | ---- | -1.17%631.59M | ---- | 267.91%639.05M | --179.73M | -11.55%173.7M | --196.37M |
| Operating profit before the change of operating capital | ---- | 13.79%-695.17M | ---- | 38.55%-806.39M | ---729.33M | -38.08%-1.31B | ---950.43M |
| Change of operating capital | |||||||
| Inventory (increase) decrease | ---- | 143.14%187.52M | ---- | -73.95%-434.68M | ---452.79M | -181.11%-249.89M | ---88.89M |
| Accounts receivable (increase)decrease | ---- | -52.80%-215.45M | ---- | 46.64%-141M | --97.4M | -696.71%-264.23M | ---33.17M |
| Accounts payable increase (decrease) | ---- | -134.58%-92.69M | ---- | 194.04%268.06M | --13.64M | 19.92%91.16M | --76.02M |
| Cash from business operations | -148.31%-2.32B | 26.77%-815.78M | 12.83%-933.61M | 35.80%-1.11B | ---1.07B | -74.14%-1.74B | ---996.47M |
| Other taxs | 94.28%-394K | ---- | ---6.89M | ---- | ---- | ---- | ---- |
| Interest received - operating | -18.30%175.28M | ---- | --214.55M | ---- | ---- | ---- | ---- |
| Special items of business | ---- | 232.18%833.39M | ---- | -454.20%-630.5M | ---94.91M | 255.40%178.01M | ---114.55M |
| Net cash from operations | -195.24%-2.14B | 101.01%17.6M | 37.74%-725.95M | -12.02%-1.74B | ---1.17B | -40.17%-1.56B | ---1.11B |
| Cash flow from investment activities | |||||||
| Decrease in deposits (increase) | ---- | ---- | ---- | 199.89%1.23B | --579.29M | 136.07%409.91M | ---1.14B |
| Sale of fixed assets | -73.06%306K | 4,244.57%4M | 1,394.74%1.14M | -86.59%92K | --76K | 88.46%686K | --364K |
| Purchase of fixed assets | 29.49%-170.6M | -106.10%-534.72M | -315.61%-241.95M | -32.07%-259.45M | ---58.22M | -12.76%-196.45M | ---174.21M |
| Purchase of intangible assets | 51.57%-131.28M | -93.90%-377.19M | -91.68%-271.08M | 44.86%-194.53M | ---141.42M | -608.12%-352.77M | ---49.82M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | --1.35M |
| Recovery of cash from investments | 152.56%13.69B | 362.79%20.41B | 156.60%5.42B | -10.80%4.41B | --2.11B | 281.60%4.94B | --1.3B |
| Cash on investment | -177.55%-15.09B | -266.21%-21.43B | -119.89%-5.44B | -16.59%-5.85B | ---2.47B | -279.98%-5.02B | ---1.32B |
| Net cash from investment operations | -222.28%-1.7B | -189.54%-1.93B | -2,668.24%-526.13M | -211.08%-667.29M | --20.49M | 84.50%-214.51M | ---1.38B |
| Net cash before financing | -206.61%-3.84B | 20.62%-1.91B | -9.30%-1.25B | -36.12%-2.41B | ---1.15B | 28.99%-1.77B | ---2.5B |
| Cash flow from financing activities | |||||||
| New borrowing | -57.31%55.95M | 193.46%294.43M | 518.63%131.05M | 701.67%100.33M | --21.18M | --12.52M | ---- |
| Issuing shares | 2,402.22%4.63B | -22.15%5.6B | --185.19M | 2,721.31%7.19B | ---- | -95.99%254.8M | --6.35B |
| Interest paid - financing | 2.14%-3.71M | 14.31%-7.41M | 17.36%-3.79M | -14.61%-8.65M | ---4.59M | -60.22%-7.55M | ---4.71M |
| Absorb investment income | ---- | --985K | --985K | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | -2,978.91%-73.12M | -17.46%-11.62M | 76.00%-2.38M | -63.55%-9.9M | ---9.9M | 49.08%-6.05M | ---11.88M |
| Net cash from financing operations | 1,507.66%4.58B | -19.45%5.82B | 1,653.04%284.73M | 3,298.52%7.22B | ---18.33M | -96.63%212.41M | --6.3B |
| Effect of rate | -167.13%-40.39M | 297.23%110.63M | 1,386.78%60.16M | -147.53%-56.09M | ---4.68M | 334.83%118M | ---50.25M |
| Net Cash | 176.35%738.59M | -18.86%3.9B | 16.88%-967.35M | 408.27%4.81B | ---1.16B | -140.99%-1.56B | --3.8B |
| Begining period cash | 35.31%15.37B | 71.89%11.36B | 71.89%11.36B | -17.91%6.61B | --6.61B | 87.38%8.05B | --4.3B |
| Cash at the end | 53.74%16.07B | 35.31%15.37B | 92.14%10.45B | 71.89%11.36B | --5.44B | -17.91%6.61B | --8.05B |
| Cash balance analysis | |||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.